作者：
Laura,Cato [1]
;
Jonas,de Tribolet-Hardy [2]
;
Irene,Lee [1]
;
Jaice T,Rottenberg [1]
;
Ilsa,Coleman [3]
;
Diana,Melchers [4]
;
René,Houtman [4]
;
Tengfei,Xiao [5]
;
Wei,Li [6]
;
Takuma,Uo [7]
;
Shihua,Sun [7]
;
Nane C,Kuznik [8]
;
Bettina,Göppert [9]
;
Fatma,Ozgun [10]
;
Martin E,van Royen [11]
;
Adriaan B,Houtsmuller [11]
;
Raga,Vadhi [1]
;
Prakash K,Rao [1]
;
Lewyn,Li [1]
;
Steven P,Balk [12]
;
Robert B,Den [13]
;
Bruce J,Trock [14]
;
R Jeffrey,Karnes [14]
;
Robert B,Jenkins [15]
;
Eric A,Klein [16]
;
Elai,Davicioni [17]
;
Friederike J,Gruhl [9]
;
Henry W,Long [1]
;
X Shirley,Liu [6]
;
Andrew C B,Cato [8]
;
Nathan A,Lack [18]
;
Peter S,Nelson [3]
;
Stephen R,Plymate [19]
;
Anna C,Groner [20]
;
Myles,Brown [21]
作者单位：
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
[1]
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
[2]
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
[3]
PamGene International B.V., 5211 HH Den Bosch, the Netherlands.
[4]
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, MA 02215, USA.
[5]
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, MA 02215, USA.
[6]
Department of Medicine, University of Washington School of Medicine and GRECC-VAPSHCS, Seattle, WA 98104, USA.
[7]
Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, 76344 Eggenstein-Leopoldshafen, Germany.
[8]
Institute of Microstructure Technology, Karlsruhe Institute of Technology, 76344 Eggenstein-Leopoldshafen, Germany.
[9]
School of Medicine, Koç University, 34450 Istanbul, Turkey.
[10]
Department of Pathology, Erasmus Optical Imaging Centre, Erasmus MC, 3015 GE Rotterdam, the Netherlands.
[11]
Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
[12]
Department of Radiation Oncology, Sidney Kimmel Cancer Center, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA.
[13]
Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
[14]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
[15]
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
[16]
GenomeDx Inc., San Diego, CA 92121, USA.
[17]
School of Medicine, Koç University, 34450 Istanbul, Turkey; Vancouver Prostate Center, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.
[18]
Department of Medicine, University of Washington School of Medicine and GRECC-VAPSHCS, Seattle, WA 98104, USA. Electronic address: splymate@u.washington.edu.
[19]
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland. Electronic address: anna.groner@hotmail.com.
[20]
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: myles_brown@dfci.harvard.edu.
[21]
DOI
10.1016/j.ccell.2019.01.008
PMID
30773341
发布时间
2020-05-26
换一批
换一批
